6505--Atorvastatin Calcium Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79723R0015
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This notice seeks offers to supply atorvastatin calcium tablets to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The VA National Acquisition Center will issue solicitation number 36E79723R0015 on April 18, 2023 to procure atorvastatin calcium tablets in various dosage strengths and package sizes. Offerors must be able to provide an uninterrupted supply for the base year plus four option years. The response deadline is May 5, 2023. Interested parties should monitor sam.gov for any changes to solicitation documents and direct any questions to the point of contact, Richard Mahario.
The solicitation has no set-aside designations and the primary NAICS code is 325412, Pharmaceutical Preparation Manufacturing. Estimated annual requirements for each dosage strength and package size are provided, ranging from approximately 90 bottles for the 10mg tablets to over 500,000 bottles for other dosages. The contract period is one base year plus four option years, indicating a potential total value well in excess of $10 million over the five-year term depending on actual usage.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0015 for an unrestrictive procurement for Atorvastatin Calcium Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79723R0015 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 18, 2023, with a tentative closing date of May 5, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to: Richard.Mahario@va.gov
The estimated annual requirements are as follows:
ITEM
DESCRIPTION
PACKAGE SIZE (TABLETS PER BOTTLE)
TOTAL ESTIMATED ANNUAL USAGE (BOTTLES)
1
ATORVASTATIN CA 10MG TAB
90
229,724
2A
ATORVASTATIN CA 10MG TAB
500
99,872
OR
OR
OR
OR
2B
ATORVASTATIN CA 10MG TAB
1000
49,936
3
ATORVASTATIN CA 20MG TAB
90
448,352
4A
ATORVASTATIN CA 20MG TAB
500
177,834
OR
OR
OR
OR
4B
ATORVASTATIN CA 20MG TAB
1000
88,917
5
ATORVASTATIN CA 40MG TAB
90
568,269
6A
ATORVASTATIN CA 40MG TAB
500
264,822
OR
OR
OR
OR
6B
ATORVASTATIN CA 40MG TAB
1000
132,411
7
ATORVASTATIN CA 80MG TAB
90
522,721
8A
ATORVASTATIN CA 80MG TAB
500
234,652
OR
OR
OR
OR
8B
ATORVASTATIN CA 80MG TAB
1000
117,326
Files
| File | Type | Posted |
|---|---|---|
| 36E79723R0015_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Atorvastatin CA Tablets - Radha Pharmaceuticals | Award Notice | |
| 6505--Atorvastatin Calcium Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Ramipril Capsules RFP | National Acquisition Center | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--Latanoprost Ophthalmic Solution (VA-27-00006027) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity